rilpivirine

noun

ril·​pi·​vir·​ine ˌril-pə-ˈvir-ˌēn 

: a reverse transcriptase inhibitor administered orally in the form of its hydrochloride C₂₂H₁₈N₆·HCl in conjunction with other antiretroviral agents in the treatment of HIV infection

Note: Rilpivirine is marketed under the trademark Edurant. It is also marketed under the trademark Complera when used in combination with emtricitabine and tenofovir disoproxil fumarate.